A.P. Pharma, Inc. Share Price Other OTC
Equities
US00202J2033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 148M 12.34B | Sales 2025 * | 178M 14.85B | Capitalization | 432M 36.08B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.17B | Net income 2025 * | 1M 83.44M | EV / Sales 2024 * | 2.92 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
-31.9
x | P/E ratio 2025 * |
430
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on A.P. Pharma, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/23/16 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/23/21 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/21/20 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/14/13 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |